Environmental factors related to multiple sclerosis progression

J Neurol Sci. 2024 Sep 15:464:123161. doi: 10.1016/j.jns.2024.123161. Epub 2024 Aug 6.

Abstract

Multiple Sclerosis (MS) is a complex neurological disease which prevalence is increasing worldwide. The impact of environmental factors on MS susceptibility has already been defined and highlighted in many previous reports, particularly vitamin D or ultraviolet B light exposure, Epstein-Barr virus (EBV) infection, obesity, and smoking. There is increasing evidence that environmental and lifestyle factors are not only important in triggering MS but are also implicated in MS progression. Low sun exposure and vitamin D deficiency exhibit a strong relationship with disease progression in both animal and human studies. The gestational period seems also to impact long-term disease progression as January's babies had a higher risk of requiring walking assistance than those born in other months. The implication of EBV in neurodegeneration and MS progression was also suggested even though its specific targets and mechanisms are still unclear. Cigarette smoking is correlated with faster clinical progression. The association of obesity and smoking seems to be associated with a faster progression and an increased rate of brain atrophy. Although the effect of air pollution on MS pathogenesis remains not fully understood, exposure to polluted air can stimulate several mechanisms that might contribute to MS severity. People with MS with active disease have an altered microbiota compared to patients in the remission phase. Cardiovascular comorbidities, epilepsy, and depression are also associated with a more severe disability accrual. Knowledge about MS modifiable risk factors of progression need to be incorporated into everyday clinical practice in order to ameliorate disease outcomes.

Keywords: Environment; Multiple sclerosis; Progression.

Publication types

  • Review

MeSH terms

  • Animals
  • Disease Progression*
  • Environmental Exposure / adverse effects
  • Epstein-Barr Virus Infections / complications
  • Humans
  • Multiple Sclerosis* / epidemiology
  • Multiple Sclerosis* / etiology
  • Risk Factors